Patients with diabetes and chronic liver disease are at increased risk for overall mortality: A population study from the United States

Clinical Diabetes

Volumn 35, Issue 2, 2017, Pages 79-83

  Stepanova, Maria ^a,b   Clement, Stephen ^a   Wong, Robert ^c   Saab, Sammy ^d   Ahmed, Aijaz ^e   Younossi, Zobair M ^a,b  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^c HIGHLAND HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CHRONIC HEPATITIS B; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; SMOKING; UNITED STATES;

EID: 85019601824     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/cd16-0018     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. Chronic diseases: the leading causes of death and disability in the United States [Internet]. Available from http://www. cdc.gov/chronicdisease/overview. Accessed 20 June 2016
2. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for US adults: National Health Interview Survey, 2010. Vital Health Stat 10 2012; 252: 1–207
3. Centers for Disease Control and Prevention/National Center for Health Statistics. Health Interview Survey, 1997–2014: sample adult core component. Early release of selected estimates based on data from the National Health Interview Survey, 2014: diagnosed diabetes [Internet]. Available from http://www.cdc.gov/nchs/ data/nhis/earlyrelease/earlyrelease 201506_14.pdf. Accessed 20 June 2016
4. Centers for Disease Control and Prevention/National Center for Health Statistics. Health Interview Survey, 1997-2014: sample adult core component. Early release of selected estimates based on data from the National Health Interview Survey, 2014: diagnosed obesity [Internet]. Available from http://www.cdc.gov/nchs/data/nhis/ earlyrelease/earlyrelease201506_06.pdf. Accessed 20 June 2016
5. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012; 307: 491–497
6. Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep 2013; 62: 1–96
7. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460–468
8. Reilly ML, Schillie SF, Smith E, et al. Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus. J Diabetes Sci Technol 2012; 6: 858–866
9. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274–285
10. Harrison SA, Togerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2008; 98: 2042–2047
11. Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009; 13: 511–531
12. Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to cirrhosis: new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol 2013; 10: 627–636
13. Targher G, Byrne CD. Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013; 98: 483–495
14. Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev 2013; 34: 84–129
15. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972–1978
16. Centers for Disease Control and Prevention. Hepatocellular carcinoma— United States, 2001–2006. MMWR Morb Mortal Wkly Rep 2010; 59: 517–520
17. Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015; 148: 547–555
18. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010; 10: 1003–1019
19. Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic fatty liver disease in Latinos. Clin Gastroenterol Hepatol 2016; 14: 5–12
20. Younossi ZM, Stepanova M, Saab S, et al. The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85, 000 liver transplant recipients in the US. Aliment Pharmacol Ther 2014; 40: 686–694